CN112250616B - Preparation method of 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylic acid tert-butyl ester - Google Patents

Preparation method of 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylic acid tert-butyl ester Download PDF

Info

Publication number
CN112250616B
CN112250616B CN202011156945.4A CN202011156945A CN112250616B CN 112250616 B CN112250616 B CN 112250616B CN 202011156945 A CN202011156945 A CN 202011156945A CN 112250616 B CN112250616 B CN 112250616B
Authority
CN
China
Prior art keywords
dihydropyridine
carboxylic acid
oxo
butyl ester
acid tert
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202011156945.4A
Other languages
Chinese (zh)
Other versions
CN112250616A (en
Inventor
潘国骏
李健
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Heju Pharmaceutical Co ltd
Original Assignee
Nanjing Heju Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Heju Pharmaceutical Co ltd filed Critical Nanjing Heju Pharmaceutical Co ltd
Priority to CN202011156945.4A priority Critical patent/CN112250616B/en
Publication of CN112250616A publication Critical patent/CN112250616A/en
Application granted granted Critical
Publication of CN112250616B publication Critical patent/CN112250616B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

The invention discloses a preparation method of 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylic acid tert-butyl ester, which comprises the following steps: dissolving 3-bromo-4-oxopiperidine-1-carboxylic acid tert-butyl ester in a solvent, adding an alkali, and reacting to obtain 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylic acid tert-butyl ester. According to the preparation method of the 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylic acid tert-butyl ester, the used raw materials of the 3-bromo-4-oxopiperidine-1-carboxylic acid tert-butyl ester, the lithium bromide, the lithium carbonate and the like are wide in source, cheap and easily available, and the 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylic acid tert-butyl ester can be quickly and efficiently obtained by only one-step reaction.

Description

Preparation method of 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylic acid tert-butyl ester
Technical Field
The invention relates to the field of organic synthesis, and in particular relates to a preparation method of 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylic acid tert-butyl ester.
Background
4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylic acid tert-butyl ester (I) is an important intermediate, can be used for carrying out 1, 4-conjugate addition reaction with boron reagent, zinc reagent, aluminum reagent and the like, and is an important raw material for synthesizing chiral piperidone. The compound I has wide application in the synthesis of molecules containing piperidine alkaloids and drugs, and has wide market prospect.
The synthesis processes reported for tert-butyl 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylate (I) are the following:
chem. commun.2005,1711-1713 reported a process for preparing I from 4-methoxypyridine (II) reduced with potassium tris (isopropoxy) borohydride, reacted with BOC-anhydride, demethylated under acidic conditions to give I in 41% overall yield, the formula:
Figure BDA0002743081090000011
reagents and conditions: a) k (i-PrO)3BH,THF,i-PrOH;b)(Boc)2O;c)10%HCl,41%for3 steps.
The potassium tri (isopropoxy) borohydride used in the method has high activity, and the potassium tri (isopropoxy) borohydride is prepared in situ from triisopropyl borate and potassium hydride when in use. Potassium hydride has high activity, releases heat and hydrogen when heated or contacted with moisture and acids, causes combustion and explosion, and has high danger when being used in large quantities. Therefore, this method is not suitable for large-scale preparation of I.
J.am. chem. soc.2011,133,14566-14569 reports a process for preparing I from N-tert-butoxycarbonyl-4-piperidone (III) by oxidation with oxygen over a palladium catalyst, of the formula:
Figure BDA0002743081090000021
reagents and conditions: 5 mol% Pd (CF)3CO2)2,O2,DMSO,80℃,48h,72%.
In the method, oxygen (O) is used2) As an oxidant, oxygen is potentially explosive in contact with organic matter. The palladium trifluoroacetate catalyst used in the reaction is high in price, the reaction time is long (48 hours are needed), and the product needs to be purified by column chromatography. Therefore, this method is not suitable for large-scale preparation of I.
Chinese patent publication No. CN106631992A discloses a process for preparing I from N-tert-butoxycarbonyl-4-piperidone (III). In the process, N-tert-butyloxycarbonyl-4-piperidone (III) reacts with elemental halogen under an alkaline condition to obtain 3-hydroxy-4, 4-dimethoxy-piperidine-1-carboxylic acid tert-butyl ester (IV), the IV is subjected to hydroxy activation and elimination to obtain 4, 4-dimethoxy-3, 4-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester (V), and the V is deprotected to obtain I, wherein the reaction formula is as follows:
Figure BDA0002743081090000022
reagents and conditions: a) i is2,KOH,MeOH,60%;b)i.(CF3SO2)2O,pyridine,CH2Cl2;ii.NaOMe,toluene,50℃,90%;c)p-TsOH,acetone,40%.
Although the reaction conditions of the process for preparing I from III are mild, the process requires 4 steps of reaction for preparing I, the total yield is low and only reaches 22%, and the process is not suitable for large-scale production.
Disclosure of Invention
Therefore, the technical problem to be solved by the present invention is to overcome the defects of long preparation route, low yield, difficult product separation and purification or use of high-risk raw material reagents in the prior art for 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylic acid tert-butyl ester, so as to provide a preparation method for 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylic acid tert-butyl ester, wherein the 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylic acid tert-butyl ester can be rapidly and efficiently obtained through one-step reaction.
In order to solve the technical problem, the invention provides a preparation method of 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylic acid tert-butyl ester, which comprises the following steps:
dissolving 3-bromo-4-oxopiperidine-1-carboxylic acid tert-butyl ester (VI) in a solvent, adding alkali, and reacting to obtain 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylic acid tert-butyl ester (I);
the reaction formula is as follows:
Figure BDA0002743081090000031
preferably, the reaction temperature is 60-180 ℃, and the reaction time is 0.5-1 h.
Preferably, the reaction temperature is 80-110 ℃, and the reaction time is 0.5-1 h.
Preferably, the molar ratio of the 3-bromo-4-oxopiperidine-1-carboxylic acid tert-butyl ester and the base is from 1:0.1 to 1: 8.
Preferably, the molar ratio of the 3-bromo-4-oxopiperidine-1-carboxylic acid tert-butyl ester and the base is from 1:1 to 1: 3.
Preferably, the base is at least one of lithium bromide, lithium carbonate, sodium carbonate, potassium carbonate or cesium carbonate, and the solvent is at least one of N, N-Dimethylformamide (DMF), N-Dimethylacetamide (DME) or N-methylpyrrolidone (NMP).
Preferably, the base is at least one of 1, 8-diazabicyclo [5.4.0] undec-7-ene (DBU) or 1, 5-diazabicyclo [4.3.0] non-5-ene (DBN), and the solvent is at least one of N, N-dimethylformamide, N-dimethylacetamide, N-methylpyrrolidone, toluene, xylene, 1, 4-dioxane, or acetonitrile.
The technical scheme of the invention has the following advantages:
1. according to the preparation method of the 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylic acid tert-butyl ester, the used raw materials of the 3-bromo-4-oxopiperidine-1-carboxylic acid tert-butyl ester, the lithium bromide, the lithium carbonate and the like are wide in source, cheap and easily available, and the 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylic acid tert-butyl ester can be quickly and efficiently obtained by only one-step reaction.
2. The preparation method of the 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylic acid tert-butyl ester provided by the invention has the advantages of short reaction time, mild conditions, simple and convenient operation, high yield, no need of column chromatography purification of the product, and suitability for large-scale production.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below, and it is obvious that the drawings in the following description are some embodiments of the present invention, and other drawings can be obtained by those skilled in the art without creative efforts.
FIG. 1 shows the preparation of tert-butyl 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylate obtained in example 1 of the present invention1H NMR chart.
Detailed Description
The following examples are provided to further understand the present invention, not to limit the scope of the present invention, but to provide the best mode, not to limit the content and the protection scope of the present invention, and any product similar or similar to the present invention, which is obtained by combining the present invention with other prior art features, falls within the protection scope of the present invention.
The examples do not show the specific experimental steps or conditions, and can be performed according to the conventional experimental steps described in the literature in the field. The reagents or instruments used are not indicated by manufacturers, and are all conventional reagent products which can be obtained commercially.
Example 1
Tert-butyl 3-bromo-4-oxopiperidine-1-carboxylate (VI) (32.00g,0.115mol,1.0equiv.) was dissolved in 200mL DMF, LiBr (16.99g,0.196mol,1.7equiv.) and lithium carbonate (21.24g,0.288mol,2.5equiv.) were added, and the reaction was stirred at 90 ℃ for 0.5h and checked by TLC for completion. The reaction was allowed to cool to room temperature, poured into 2L of water, extracted with ethyl acetate (200mL x 2) and the organic phases combined. The organic phase was washed with saturated brine (300mL x 3), dried over anhydrous sodium sulfate, concentrated under reduced pressure to give a yellow oil, left to stand for a while to become a solid, slurried with n-heptane, filtered and dried to give a white solid, 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylic acid tert-butyl ester (15.09 g). Yield: 66.5 percent. The reaction formula involved in the process is:
Figure BDA0002743081090000051
as shown in figure 1 of the drawings, in which,1HNMR(400MHz,CDCl3):δ(ppm)7.82(brs,1H),5.31(d,J=8.32Hz,1H),3.98(t,J=7.36Hz,1H),2.55(t,J=7.36Hz,2H),1.54(s,9H)。
the successful preparation of tert-butyl 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylate is verified by FIG. 1.
Example 2
Tert-butyl 3-bromo-4-oxopiperidine-1-carboxylate (VI) (20.00g,0.072mol,1.0equiv.) was dissolved in 100mL NMP, LiBr (18.73g,0.216mol,3.0equiv.) was added, the reaction was carried out at 110 ℃ for 0.5h, and the reaction was complete by TLC. The reaction was allowed to cool to room temperature, poured into 1L of water, extracted with ethyl acetate (100mL x 2) and the organic phases combined. The organic phase was washed with saturated brine (200 mL. multidot.3), dried over anhydrous sodium sulfate, concentrated under reduced pressure to give a yellow oil, which was put into a refrigerator to precipitate a solid, which was slurried with n-heptane, filtered and dried to give a white solid, 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylic acid tert-butyl ester (6.80 g). Yield: 48.0 percent.
Example 3
Tert-butyl 3-bromo-4-oxopiperidine-1-carboxylate (VI) (10.00g,0.036mol,1.0equiv.) was dissolved in 100mL of N, N-dimethylacetamide, sodium carbonate (15.24g,0.144mol,4.0equiv.) was added, the reaction was carried out at 80 ℃ for 1 hour, and the completion of the reaction was detected by TLC. The reaction was allowed to cool to room temperature, poured into 1L of water, extracted with ethyl acetate (100mL x 2) and the organic phases combined. The organic phase was washed with saturated brine (200mL × 3), dried over anhydrous sodium sulfate, and concentrated under reduced pressure to give a yellow oil, which was purified by silica gel column chromatography (petroleum ether: ethyl acetate: 6: 1) to obtain 2.71g of 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylic acid tert-butyl ester as a white solid, with a yield of 38.3%.
Example 4
Tert-butyl 3-bromo-4-oxopiperidine-1-carboxylate (VI) (10.00g,0.036mol,1.0equiv.) is dissolved in 80mL toluene, 1, 8-diazabicyclo [5.4.0] undec-7-ene (DBU, 6.57g,0.043mol,1.2equiv.) is added and the reaction is completed by TLC at 80 ℃ for 1 h. The reaction is cooled to room temperature, 50mL of ethyl acetate is added, silica gel is filtered, the filtrate is decompressed and concentrated to obtain yellow oily matter, the yellow oily matter is put into a refrigerator to precipitate solid, n-heptane is used for pulping, and the white solid, namely the 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylic acid tert-butyl ester, is obtained after filtration and drying, and 3.95g of the white solid is obtained. Yield: 55.7 percent.
Example 5
Tert-butyl 3-bromo-4-oxopiperidine-1-carboxylate (VI) (2.00g,7.19mmol,1.0equiv.) is dissolved in 40mL acetonitrile, 1, 5-diazabicyclo [4.3.0] non-5-ene (DBN, 2.32g,18.70mmol,2.6equiv.) is added, the reaction is carried out at 100 ℃ for 1h, and the reaction is detected by TLC to be complete. The reaction is cooled to room temperature, 50mL of n-heptane is added, silica gel is filtered, the filtrate is decompressed and concentrated to obtain yellow oily matter, the yellow oily matter is put into a refrigerator to precipitate solid, the n-heptane is pulped, and the white solid 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylic acid tert-butyl ester is obtained after filtration and drying, wherein 0.73g of the white solid is obtained. Yield: 51.5 percent.
It should be understood that the above examples are only for clarity of illustration and are not intended to limit the embodiments. Other variations and modifications will be apparent to persons skilled in the art in light of the above description. And are neither required nor exhaustive of all embodiments. And obvious variations or modifications therefrom are within the scope of the invention.

Claims (4)

1. A preparation method of 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylic acid tert-butyl ester is characterized by comprising the following steps:
dissolving 3-bromo-4-oxopiperidine-1-carboxylic acid tert-butyl ester in a solvent, adding an alkali, reacting at 60-180 ℃ for 0.5-1H to obtain 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylic acid tert-butyl ester;
the reaction formula is as follows:
Figure DEST_PATH_IMAGE002
the alkali is at least one of lithium bromide, lithium carbonate, sodium carbonate, potassium carbonate or cesium carbonate, and the solvent is at least one of N, N-dimethylformamide, N-dimethylacetamide or N-methylpyrrolidone;
or, the base is at least one of 1, 8-diazabicyclo [5.4.0] undec-7-ene or 1, 5-diazabicyclo [4.3.0] non-5-ene, and the solvent is at least one of N, N-dimethylformamide, N-dimethylacetamide, N-methylpyrrolidone, toluene, xylene, 1, 4-dioxane, or acetonitrile.
2. The process for the preparation of tert-butyl 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylate according to claim 1, characterized in that the reaction temperature is 80-110 ℃ and the reaction time is 0.5-1H.
3. The process for the preparation of tert-butyl 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylate according to claim 1 or 2, characterized in that the molar ratio of tert-butyl 3-bromo-4-oxopiperidine-1-carboxylate and base is 1:0.1-1: 8.
4. The process for the preparation of tert-butyl 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylate according to claim 1 or 2, characterized in that the molar ratio of tert-butyl 3-bromo-4-oxopiperidine-1-carboxylate and base is 1:1 to 1: 3.
CN202011156945.4A 2020-10-26 2020-10-26 Preparation method of 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylic acid tert-butyl ester Active CN112250616B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011156945.4A CN112250616B (en) 2020-10-26 2020-10-26 Preparation method of 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylic acid tert-butyl ester

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011156945.4A CN112250616B (en) 2020-10-26 2020-10-26 Preparation method of 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylic acid tert-butyl ester

Publications (2)

Publication Number Publication Date
CN112250616A CN112250616A (en) 2021-01-22
CN112250616B true CN112250616B (en) 2022-03-18

Family

ID=74262886

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011156945.4A Active CN112250616B (en) 2020-10-26 2020-10-26 Preparation method of 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylic acid tert-butyl ester

Country Status (1)

Country Link
CN (1) CN112250616B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106631992A (en) * 2017-01-05 2017-05-10 桑迪亚医药技术(上海)有限责任公司 Synthesis method of 4-oxy-3,4-dihydro-2H-pyridine-1-tert-butyl formate

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106631992A (en) * 2017-01-05 2017-05-10 桑迪亚医药技术(上海)有限责任公司 Synthesis method of 4-oxy-3,4-dihydro-2H-pyridine-1-tert-butyl formate

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Synthesis of Cyclic Enones via Direct Palladium-Catalyzed Aerobic;Tianning Diao,等;《J. Am. Chem. Soc》;20110818;第14566-14569页 *

Also Published As

Publication number Publication date
CN112250616A (en) 2021-01-22

Similar Documents

Publication Publication Date Title
CN112250616B (en) Preparation method of 4-oxo-3, 4-dihydropyridine-1 (2H) -carboxylic acid tert-butyl ester
CN112552224A (en) Synthesis method of 4-hydroxyindole
CN113248432A (en) Novel method for preparing intermediate of roxasistat in high yield
CN111170947A (en) Preparation method of telmisartan impurity J
CN111004198A (en) Synthetic method of benzopyran derivative
CN115594639A (en) Synthesis method of key intermediate of Tegolrazan
CN115536593A (en) Scalable production method of 4-hydroxy-N, N, 2-trimethylbenzimidazole-6-formamide
CN115611860B (en) Method for synthesizing nilaparib
CN115141134B (en) Compound and preparation method and application thereof
CN111533689B (en) 2,2' -biquinoline compound and one-pot preparation method thereof
CN109824661B (en) Preparation method of impurities in penehyclidine hydrochloride
CN113214256A (en) Synthesis method of 1, 7-diazaspiro [3.5] nonane-7-tert-butyl formate
CN114957163B (en) Preparation method of N-methyl homopiperazine
CN113248380B (en) Synthetic method of acetic acid alpha-asaryl alcohol ester and alpha-fine octanol
CN105017219B (en) Synthetic method for p53-MDM2-binding inhibitor dyhydroxyl quinoline derivative
CN108892676A (en) A kind of synthetic method of Ofloxacin and lavo-ofloxacin
CN112608267B (en) Synthetic method of 4-phenyl-2-pyrrolidone
CN115448871B (en) Preparation method of tirofiban hydrochloride
CN113200997B (en) Synthesis method of 2, 5-dioxa-8-azaspiro [3.5] nonane and salt thereof
CN115894503A (en) Preparation method of azacyclopentane derivative
JPS61151194A (en) Production of thiophane derivative
CN115611739A (en) Preparation method of benzoic acid intermediate and intermediate thereof
CN1962626A (en) 1-methylamino-1- methylthio-2-nitroethylene synthesis method
CN118619960A (en) Application of ligand catalyst in synthesizing indole alkaloid
CN116554192A (en) Synthesis method of 8-methoxy psoralen

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant